Kalina T Belcheva, Priyanka Chowdhury, Vivian L S Kuan, William Alread, Dulguun Baasan, Jennifer K Lue, Stephanie Downs-Canner, Richard L Frock, William T Yewdell, Jayanta Chaudhuri
{"title":"A hyper-IgM2 AID mutation limits IgH break formation but preserves affinity maturation.","authors":"Kalina T Belcheva, Priyanka Chowdhury, Vivian L S Kuan, William Alread, Dulguun Baasan, Jennifer K Lue, Stephanie Downs-Canner, Richard L Frock, William T Yewdell, Jayanta Chaudhuri","doi":"10.1016/j.celrep.2026.118221","DOIUrl":null,"url":null,"abstract":"<p><p>Activation-induced cytidine deaminase (AID) drives antibody diversification through class switch recombination (CSR) and somatic hypermutation (SHM). Humans with an AID mutation deleting the last nine amino acids (AID<sup>R190X</sup>) develop hyper-IgM syndrome with defective CSR but variable SHM, suggesting that the C terminus plays a marked role in CSR. To model this putative separation-of-function mutation, we generated an Aicda<sup>R190X</sup> knock-in mouse. These mice show a severe CSR defect and a moderately reduced but ongoing SHM. Mechanistically, the severe CSR defect correlates with defective recombination of double-strand breaks in immunoglobulin switch regions. Strikingly, fusion of AID<sup>R190X</sup> to a catalytically inactive AID restores CSR, indicating that the C terminus mediates a non-catalytic function for recombination. This mouse model of the human R190X mutation demonstrates that the AID C terminus is indispensable for CSR and also contributes to efficient SHM, providing insight into the mechanistic basis of hyper-IgM immunodeficiency.</p>","PeriodicalId":9798,"journal":{"name":"Cell reports","volume":"45 11","pages":"118221"},"PeriodicalIF":7.7000,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell reports","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.celrep.2026.118221","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Activation-induced cytidine deaminase (AID) drives antibody diversification through class switch recombination (CSR) and somatic hypermutation (SHM). Humans with an AID mutation deleting the last nine amino acids (AIDR190X) develop hyper-IgM syndrome with defective CSR but variable SHM, suggesting that the C terminus plays a marked role in CSR. To model this putative separation-of-function mutation, we generated an AicdaR190X knock-in mouse. These mice show a severe CSR defect and a moderately reduced but ongoing SHM. Mechanistically, the severe CSR defect correlates with defective recombination of double-strand breaks in immunoglobulin switch regions. Strikingly, fusion of AIDR190X to a catalytically inactive AID restores CSR, indicating that the C terminus mediates a non-catalytic function for recombination. This mouse model of the human R190X mutation demonstrates that the AID C terminus is indispensable for CSR and also contributes to efficient SHM, providing insight into the mechanistic basis of hyper-IgM immunodeficiency.
期刊介绍:
Cell Reports publishes high-quality research across the life sciences and focuses on new biological insight as its primary criterion for publication. The journal offers three primary article types: Reports, which are shorter single-point articles, research articles, which are longer and provide deeper mechanistic insights, and resources, which highlight significant technical advances or major informational datasets that contribute to biological advances. Reviews covering recent literature in emerging and active fields are also accepted.
The Cell Reports Portfolio includes gold open-access journals that cover life, medical, and physical sciences, and its mission is to make cutting-edge research and methodologies available to a wide readership.
The journal's professional in-house editors work closely with authors, reviewers, and the scientific advisory board, which consists of current and future leaders in their respective fields. The advisory board guides the scope, content, and quality of the journal, but editorial decisions are independently made by the in-house scientific editors of Cell Reports.